NDTV News

Oxford University's COVID-19 Vaccine Shows Promise In Early Testing

The vaccine is under development by AstraZeneca, scientists at UK’s Oxford University (Representational)

London:

AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.

The vaccine, called AZD1222 and under development by AstraZeneca and scientists at Britain’s Oxford University, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here

four × 3 =